Genesis of tramsmissible protein states via deformed templating

Prion

Volumn 6, Issue 3, 2012, Pages 252-255

  Makarava, Natallia ^a   Baskakov, Ilia V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid fibrils; Infectivity; Neurodegenerative diseases; Prion diseases; Prion protein; Template assisted mechanism

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID A PROTEIN; PRION PROTEIN; TAU PROTEIN;

AMYLOIDOSIS; DEGENERATIVE DISEASE; DNA TEMPLATE; EVOLUTION; INOCULATION; NONHUMAN; PRION; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SYNTHESIS; REVIEW; VIRUS REPLICATION; VIRUS TRANSFORMATION; VIRUS TRANSMISSION;

AMYLOID; ANIMALS; HUMANS; PRION DISEASES; PRIONS; PROTEIN CONFORMATION; PROTEIN FOLDING;

ANIMALIA;

EID: 84863681623     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.19930     Document Type: Review

References (24)

1. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83; PMID:9811807; http://dx.doi. org/10.1073/pnas.95.23.13363.
2. Cohen FE, Prusiner SB. Pathologic conformations of prion proteins. Annu Rev Biochem 1998; 67:793- 819; PMID:9759504; http://dx.doi.org/10.1146/ annurev.biochem.67.1.793.
3. Legname G, Baskakov IV, Nguyen HOB, Riesner D, Cohen FE, DeArmond SJ, et al. Synthetic mammalian prions. Science 2004; 305:673-6; PMID:15286374; http://dx.doi.org/10.1126/science.1100195.
4. Castilla J, Saá P, Hetz C, Soto C. In vitro generation of infectious scrapie prions. Cell 2005; 121:195- 206; PMID:15851027; http://dx.doi.org/10.1016/j. cell.2005.02.011.
5. Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003; 425:717-20; PMID:14562104; http://dx.doi. org/10.1038/nature01979.
6. Makarava N, Kovacs GG, Savtchenko R, Alexeeva I, Budka H, Rohwer RG, et al. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog 2011; 7:1002419; PMID:22144901; http://dx.doi.org/10.1371/journal. ppat.1002419.
7. Wille H, Bian W, McDonald M, Kendall A, Colby DW, Bloch L, et al. Natural and synthetic prion structure from X-ray fiber diffraction. Proc Natl Acad Sci USA 2009; 106:16990-5; PMID:19805070; http://dx.doi.org/10.1073/pnas.0909006106.
8. Ostapchenko VG, Sawaya MR, Makarava N, Savtchenko R, Nilsson KP, Eisenberg D, et al. Two amyloid States of the prion protein display significantly different folding patterns. J Mol Biol 2010; 400:908-21; PMID:20553730; http://dx.doi. org/10.1016/j.jmb.2010.05.051.
9. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, Rohwer RG, et al. Highly efficient protein misfolding cyclic amplification. PLoS Pathog 2011; 7:1001277; PMID:21347353; http://dx.doi.org/10.1371/journal. ppat.1001277.
10. Makarava N, Kovacs GG, Bocharova OV, Savtchenko R, Alexeeva I, Budka H, et al. Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol 2010; 119:177- 87; PMID:20052481; http://dx.doi.org/10.1007/ s00401-009-0633-x.
11. Hill AF, Collinge J. Subclinical prion infection. Trends Microbiol 2003; 11:578-84; PMID:14659690; http://dx.doi.org/10.1016/j.tim.2003.10.007.
12. Makarava N, Ostapchenko VG, Savtchenko R, Baskakov IV. Conformational switching within individual amyloid fibrils. J Biol Chem 2009; 284:14386- 95; PMID:19329794; http://dx.doi.org/10.1074/jbc. M900533200.
13. Ventura S, Zurdo J, Narayanan S, Parreño M, Mangues R, Reif B, et al. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci USA 2004; 101:7258-63; PMID:15123800; http:// dx.doi.org/10.1073/pnas.0308249101.
14. Ivanova MI, Sawaya MR, Gingery M, Attinger A, Eisenberg D. An amyloid-forming segment of beta2- microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA 2004; 101:10584- 9; PMID:15249659; http://dx.doi.org/10.1073/ pnas.0403756101.
15. Tessier PM, Lindquist S. Prion recognition elements govern nucleation, strain specificity and species barriers. Nature 2007; 447:556-61; PMID:17495929; http://dx.doi.org/10.1038/nature05848.
16. Chen B, Bruce KL, Newnam GP, Gyoneva S, Romanyuk AV, Chernoff YO. Genetic and epigenetic control of the efficiency and fidelity of cross-species prion transmission. Mol Microbiol 2010; 76:1483- 99; PMID:20444092; http://dx.doi.org/10.1111/ j.1365-2958.2010.07177.x.
17. Jucker M, Walker LC. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 2011; 70:532-40; PMID:22028219; http://dx.doi.org/10.1002/ ana.22615.
18. Cushman M, Johnson BS, King OD, Gitler AD, Shorter J. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 2010; 123:1191-201; PMID:20356930; http:// dx.doi.org/10.1242/jcs.051672.
19. Colby DW, Giles K, Legname G, Wille H, Baskakov IV, DeArmond SJ, et al. Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci USA 2009; 106:20417-22; PMID:19915150; http:// dx.doi.org/10.1073/pnas. 0910350106.
20. Colby DW, Wain R, Baskakov IV, Legname G, PAlmer CG, Nguyen HO, et al. Protease-sensitive synthetic prions. PLoS Pathogen 2010; 6:1000736.
21. Lundmark K, Westermark GT, Olsén A, Westermark P. Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism. Proc Natl Acad Sci USA 2005; 102:6098-102; PMID:15829582; http://dx.doi. org/10.1073/pnas.0501814102.
22. Westermark P, Lundmark K, Westermark GT. Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model. PLoS One 2009; 4:6041; PMID:19582162; http://dx.doi.org/10. 1371/journal. pone.0006041.
23. Derkatch IL, Bradley ME, Hong JY, Liebman SW. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell 2001; 106:171-82; PMID:11511345; http://dx.doi.org/10.1016/S0092- 8674(01)00427-5.
24. +] prion in yeast and aggregation of Sup35 in vitro. Proc Natl Acad Sci USA 2004; 101:12934-9; PMID:15326312; http://dx.doi. org/10.1073/pnas.0404968101.